Analyst firms · Morgan Stanley · ISRG

Morgan Stanley ISRG price target and rating history

Intuitive Surgical Inc. (ISRG) · Health Care

Morgan Stanley rates Intuitive Surgical Inc. (ISRG) Overweight with a $650 price target, as of its latest action on Dec 2, 2024. It has published 7 rating actions on ISRG since July 2021, including 1 upgrade and 0 downgrades. Across 7 firms with a ISRG price target in the last 12 months, the median target is $500.

Current rating
Overweight
Price target
$650
Median target, all firms
$500
Actions on ISRG
7

Morgan Stanley price target on ISRG

$930$608$28520222023202420252026
Morgan Stanley price target on ISRG, each point a stated target, July 2021 to December 2024.

Every Morgan Stanley rating on ISRG

How other firms rate ISRG

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Erste GroupBuyOct 21, 2026
BarclaysOverweight$485Oct 7, 2026
OppenheimerOutperform$500Aug 12, 2026
HSBCHold$391Jul 30, 2026
UBSBuy$500Jul 28, 2026
BMO Capital MarketsOutperform$518Jul 9, 2026
CitigroupBuy$590Mar 11, 2026
TD CowenBuy$660Jan 27, 2026

Questions about Morgan Stanley and ISRG

What is Morgan Stanley's price target for ISRG?
Morgan Stanley's latest stated price target for Intuitive Surgical Inc. (ISRG) is $650, from its action on Dec 2, 2024.
What is Morgan Stanley's rating on ISRG?
Morgan Stanley rates ISRG Overweight, a bullish rating, as of Dec 2, 2024.
When did Morgan Stanley last change its view on ISRG?
On Dec 2, 2024, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $522 to $650.
How does Morgan Stanley's ISRG target compare with other analysts?
Across 7 firms with a ISRG price target in the last 12 months, the median target is $500.

More ISRG rating histories

All Morgan Stanley ratingsISRG news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.